We know the process of finding medications for mental health conditions like depression, anxiety or ADHD can be time-consuming and debilitating. The GeneSight® test may help.
What is GeneSight
Get Started
What is the Cost
Sample Report
How Does It Work
TestimonialsIs the GeneSight Test Right for You?
Has a mental health medication failed you in the past? Is your current mental health medication not working? Does your mental health medication cause unwanted side effects?
2 Million+
people have taken the GeneSight test
Thousands
of clinicians registered to offer the GeneSight test
$1,000 saved
on average in total annual medication costs by patients who received GeneSight testing compared to traditional approaches, according to a large study1
What is the GeneSight Psychotropic Test?
The GeneSight Psychotropic test is a genetic test that shows your healthcare provider how your genes may affect medication outcomes.
The GeneSight test may reveal which medications to treat depression, anxiety, ADHD, and other mental health conditions that:
Require dose adjustments Be less likely to work Have an increased risk of side effects based on your DNAYour Mental Health Journey with GeneSight Starts Here
Do you have a healthcare provider?
If you have a clinician who you’d like to work with in getting the GeneSight test.
If you do not have a clinician in mind, please use our Find a Provider Tool below to see a list of registered GeneSight providers in your area.
Cost Shouldn’t Be a Barrier to Your Mental Wellness
Our goal is to make the GeneSight test affordable and accessible to patients.
 |
Many insurance plans, including Medicare, often cover the entire or a significant portion of the test. |
 |
We offer a financial assistance plan for eligible patients to help with the cost of the GeneSight test. Use our cost estimator to see if you qualify. |
 |
If your cost is $100 or more, we offer an interest-free payment plan to spread out the cost for up to 12 months. |
98%
of patients pay $330 or less
for their GeneSight test*
of patients pay $330 or less
for their GeneSight test*
$0
is the typical out-of-pocket cost for patients
on Medicare (Part B) and Medicaid
is the typical out-of-pocket cost for patients
on Medicare (Part B) and Medicaid
We promise that if your cost could be more than $330, we’ll contact you before we process your test to discuss our financial assistance program and interest-free payment plan and give you the chance to cancel.
* Based on a review of six months of past claim data for major insurance carriers across the US, over 98% of patients pay $330 or less for their GeneSight test. Last updated 2023.
A Comprehensive Report, Personalized for You
The GeneSight test results do not provide information on disease diagnosis, medication allergies, drug-drug interactions, or which medications will work best.
The GeneSight test provides genetic insights to help inform your clinician’s treatment plan, potentially reducing medication trial and error, and shortening your road to recovery.
The report classifies over 60 mental health medications into four categories:
Use as Directed
Moderate Gene-Drug Interaction
Significant Gene-Drug Interaction
No Proven Genetic Markers
The report also includes information on how a patient’s smoking status may affect their body’s metabolism of certain medications.
Hear how the GeneSight test benefited others like you.
The GeneSight test results do not provide information on disease diagnosis, medication allergies, drug-drug interactions, or which medications will work best.
How Does It Work?
The GeneSight test is a simple cheek swab taken in your clinician’s office
can be ordered and sent by your clinician to be taken in the convenience of your home via GeneSight at Home.
The sample is sent to our lab for analysis. After we receive your sample, we send results to your clinician typically within about 2 days.
Your clinician can review your results on the next visit. The results may be used by your healthcare provider to help inform your mental health medication treatment.
Refer a Provider
Find a Provider1Winner, et al, Current Medical Research and Opinion, 2015;31(9): 1633-43